MotionHall
MotionHall operates a SaaS platform and senior advisory service that helps biotech and pharmaceutical executives identify partners, evaluate deals, and prioritize pipelines through a proprietary AI-powered digital twin of the global biopharmaceutical landscape.
- Company typePrivate
- Founded2015
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What MotionHall does
MotionHall is a privately held, venture-backed software and advisory company that operates a SaaS platform for biopharmaceutical business development and dealmaking. The company serves biotech and pharmaceutical executives across licensing, M&A, and pipeline strategy workflows, with named segments spanning emerging and clinical-stage biotechs, mid-to-large specialty and top-tier pharma, investment banks and financial advisors, and C-suite/board-level decision-makers at life sciences companies. Its core technology is the MotionHall Model, a proprietary digital twin of the global biopharmaceutical landscape built on a multi-terabyte labeled dataset combined with massively indexed public sources such as Clinical Trials, Patents, and PubMed, and powered by custom domain-specific AI models for classification, prediction, and regression. The platform exposes deal enablement workspaces including OutMatch (out-licensing/sell-side M&A), InMatch (in-licensing/buy-side M&A), Deal Comparables, Competitive Landscape Evaluation, the Top Pharma Suite, and the OnMethod Platform for strategic outreach campaigns. MotionHall is headquartered in Vancouver, BC, with senior Strategy Consulting leadership in San Francisco and London, and serves members across North America, Europe, Asia Pacific, Latin America, Israel, and India.
The company monetizes through non-cancelable, non-refundable annual platform subscriptions bundled with downloadable client software and attached professional services delivered via Statement of Work, including strategy consulting, bespoke analysis, workshops, market development, outreach campaign execution, and deal collateral development. The sales motion is direct enterprise field sales targeting C-suite, board, and senior BD&L buyers with a credible budget, managed end-to-end by the senior Strategy Consulting team. MotionHall was founded in 2015 by Rachael Craig (CEO) and Matthew Jewkes (CTO), is backed by Village Global, First Star Ventures, and Outlier Ventures, and is supported by a senior advisory bench drawn from Genentech, Veeva, and Palantir. The engineering team includes contributors to the Signal iOS and Rust-Axolotl Double Ratchet Cryptography implementations.
MotionHall firmographics
Firmographics- Name
- MotionHall
- Legal name
- MotionHall Inc.
- Website
- https://motionhall.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MotionHall operates a SaaS platform and senior advisory service that helps biotech and pharmaceutical executives identify partners, evaluate deals, and prioritize pipelines through a proprietary AI-powered digital twin of the global biopharmaceutical landscape.
- Ownership category
- akta.pro rank
MotionHall industry classification
Industry- Product category
- Biopharma Deal Intelligence Software
- NAICS
- Wholesale Trade Agents and Brokers (425)
- akta.pro primary industry
- Business-for-Sale Marketplaces & Listing Platforms (FSAEAIAK)
Keywords
Where MotionHall is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
MotionHall business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform Subscription (SaaS): MotionHall licenses access to its proprietary MotionHall Platform (SaaS) for pharmaceutical market intelligence, predictive advisory, and deal transactability. Fees are subscription-based, payable in advance, non-refundable, and non-cancelable during the term. Quantities purchased cannot be decreased during the relevant term.
- Professional Services and Strategy Consulting: MotionHall performs professional services including strategy consulting, bespoke analysis, workshops, market development, outreach campaign design and execution, and deal support. Services are delivered via Statement of Work (SOW), with prepayment required before commencement. Professional services include Deliverables acceptance cycles and change order processes.
- MotionHall Software (Downloadable Client Software): MotionHall provides downloadable client software that runs on customer systems, automatically updating and upgrading. All updates, upgrades, and maintenance are included with the Fees. This component is bundled with the Platform subscription.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Platform Access Subscription |
| Subscription | Annual | OutMatch Unlimited Package |
| Other | Multi-year contract | Professional Services (Statement of Work) |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
MotionHall product offering
Product offeringCore offering
MotionHall sells enterprise subscriptions to its proprietary biopharma dealmaking SaaS Platform, powered by the MotionHall Model — a digital twin of the global biopharma landscape built on multi-terabyte labeled datasets and custom AI models. Key workspaces include OutMatch (out-licensing and sell-side M&A), InMatch (in-licensing and buy-side M&A), Deal Comparables, Competitive Landscape Evaluation, Top Pharma Suite, and OnMethod outreach campaigns. The platform is sold together with senior Strategy Consulting services delivered via Statement of Work.
Product overview
MotionHall is a Silicon Valley technology company offering a SaaS platform for biopharmaceutical business development and dealmaking. The core offering consists of the MotionHall Platform and MotionHall Model (a proprietary digital twin of the global biopharma landscape). The platform is complemented by specialized deal enablement tools including OutMatch Professional (out-licensing and sell-side M&A workspace), InMatch (in-licensing platform), Deal Comparables, and Competitive Landscape Evaluation. Additional modules include the Top Pharma Suite for large corporate teams and the OnMethod Platform for strategic outreach campaigns. Professional services are delivered through MotionHall's Strategy Consulting team, including OnMethod Deck and Data Room for deal collateral support.
Differentiator
Problem solved
Functional benefit
Products and services
- MotionHall Platform Web-based SaaS platform providing biopharma dealmakers with strategic intelligence for IP portfolio management and transactions, including partner matching, deal comparables, and competitive landscape analysis. Sold via annual subscription to senior biopharma executives and their teams worldwide.
- OutMatch (Out-Licensing and Sell-Side M&A Workspace) Deal workspace for out-licensing and sell-side M&A that runs proprietary matching algorithms across every global biopharma company, identifying probability of transaction and quality of fit. Includes Scientific Synergies, Key Contacts, Competitive Landscape, and Deal Comparables modules for biotech business development teams.
- InMatch (In-Licensing and Buy-Side M&A) Platform for in-licensing workflows that helps biotech CEOs identify best-fit assets for their pipeline based on strategic criteria including indication, development stage, and commercial goals. Includes competitive set analysis and M&A attractiveness evaluation.
- Top Pharma Suite Workflows and tools for top pharma in-licensing and corporate development teams, supporting large corporate teams with coordination around strategically aligned opportunities, powered by AI integration points connected to MotionHall's Pharmaceutical Industry Model.
- MotionHall Strategy Consulting Senior strategy consulting team providing expert advisory services, custom workshops, and elastic BD team support for platform strategy, deal cycles, and market development. Engagements are scoped via Statement of Work with prepayment required before commencement.
- OnMethod Outreach Campaign Services Strategic outreach service delivering precision-tailored email campaigns, presentations, and data rooms for licensing, market development, and corporate development, executed by MotionHall's Outreach Campaign Manager and consultants.
- OnMethod Deck and Data Room Consulting service supporting members in licensing, M&A, private financings, and IPOs with workshops and processes producing high-conversion deal collateral, including tailored decks and data room materials.
Quantifiable outcome
- MotionHall membership has developed more than $6 billion in company value through venture investment, strategic partnerships, and company M&A since 2016.
- +3 more outcomes
Companies that use MotionHall
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles3 records
MotionHall technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
MotionHall partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor.
- Genentech (Senior Advisors)minorSenior advisors from Genentech support MotionHall's strategic direction and industry expertise. Dr. Rod Ferguson, former Senior Director of Business and Corporate Development at Genentech responsible for worldwide licensing transactions including Genentech's in-licensing of Rituxan and auction of Herceptin, serves as a senior advisor and board member to MotionHall.
- Veeva (Senior Advisors)minorSenior advisors from Veeva Systems provide MotionHall with technology company operational expertise and industry credibility in the life sciences software space.
- Palantir (Senior Advisors)minorSenior advisors from Palantir Technologies contribute frontier technology expertise and data engineering perspective to MotionHall's product and platform development.
- Panorama Capital / Rod FergusonminorDr. Rod Ferguson, Managing Director of Panorama Capital (spun off from J.P. Morgan Partners), serves as a senior advisor, board member, mentor and investor at MotionHall. He brings transactional experience from all sides of the table: biotech, pharmaceutical company, venture investor, and investment banker. He led Genentech's most widely recognized licensing deals.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
MotionHall competitors and assessment
Company assessmentBroad incumbents
- Citeline (Informa Pharma Intelligence): Citeline (formerly Pharma Intelligence, part of Informa) is a broad incumbent offering extensive pharma pipeline, trial, deal, and competitive intelligence across multiple products. It overlaps with MotionHall in biopharma deal intelligence and BD analytics, but as part of a much wider portfolio.
- EvaluatePharma: EvaluatePharma (part of Norstella) provides pharma market intelligence, forecasts, and deal benchmarking. It is comparable to MotionHall on the deal-comparables and pharma market intelligence axes, but as a much larger incumbent with broader coverage of the full pharma value chain.
- PharmaCircle: PharmaCircle is a pharma competitive intelligence platform covering pipeline, deals, products, and companies. It is an incumbent comparable to MotionHall's deal comparables and competitive landscape modules, though without MotionHall's AI-driven digital twin or senior consulting overlay.
- IQVIA: IQVIA is a global life sciences intelligence and technology provider covering R&D, clinical, commercial, and market data. Its pharma intelligence and deal-related data offerings overlap with MotionHall's BD-focused digital twin, though IQVIA serves far broader customer use cases across pharma.
- GlobalData: GlobalData provides deal, pipeline, and market intelligence across pharma and several other industries. It overlaps with MotionHall on pharma deal intelligence and competitive benchmarking, but as a much broader data and analytics platform.
- Biomedtracker: Biomedtracker (part of Informa/Skyward) provides pharma R&D, clinical, and deal intelligence used by biotech BD teams. It is comparable to MotionHall in serving the same buyer with deal and pipeline context, but as part of a broader pharma intelligence suite.
- AdisInsight: AdisInsight (part of Springer Nature) offers drug development, clinical trial, and deals intelligence for pharma and biotech BD professionals. It is an incumbent comparable to MotionHall on the deals-and-pipeline intelligence axis serving biopharma licensing and corporate development teams.
Emerging players
- Dealroom.co: Dealroom is a startup/innovation and deal intelligence platform with growing coverage of biopharma funding and M&A. It is an emerging player that intersects with MotionHall's market intelligence and partner-identification use cases, though it does not specialize in biopharma or offer embedded consulting.
Direct peers
- BioCentury: BioCentury is a long-established biopharma business intelligence and BD advisory publication serving biotech licensing and partnering teams. It competes with MotionHall in providing deal intelligence, partnering context, and BD workflow support for the same senior biopharma executives.
- DealForma: DealForma is a biopharma deal analytics platform that tracks licensing, partnership, and M&A transactions. It is the closest direct peer to MotionHall, addressing the same buyer (biopharma BD teams) with a deal-data and intelligence workflow, though without the embedded senior Strategy Consulting layer.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
MotionHall social profiles
Digital presenceMotionHall financial estimates
Financial estimateRevenue estimate
Valuation estimate
MotionHall leadership team
Management profileNumber of profiles
Profiles14 records
MotionHall funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MotionHall M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MotionHall
What does MotionHall do?
MotionHall sells enterprise subscriptions to its proprietary biopharma dealmaking SaaS Platform, powered by the MotionHall Model — a digital twin of the global biopharma landscape built on multi-terabyte labeled datasets and custom AI models. Key workspaces include OutMatch (out-licensing and sell-side M&A), InMatch (in-licensing and buy-side M&A), Deal Comparables, Competitive Landscape Evaluation, Top Pharma Suite, and OnMethod outreach campaigns. The platform is sold together with senior Strategy Consulting services delivered via Statement of Work.
Is MotionHall a public or private company?
MotionHall is a private company. It is classified as venture growth investor backed and is currently operating.
When was MotionHall founded?
MotionHall was founded in 2015. It employs 1 to 10 people.
Where is MotionHall based?
MotionHall is headquartered in San Francisco, United States, in the North America region.
How does MotionHall make money?
Three revenue lines are on record. Platform Subscription (SaaS) is the primary driver. The others are professional Services and Strategy Consulting and motionHall Software (Downloadable Client Software).
Who are MotionHall's main competitors?
Broad incumbents on record are Citeline (Informa Pharma Intelligence), EvaluatePharma, PharmaCircle, IQVIA, GlobalData, Biomedtracker and AdisInsight. Dealroom.co is listed as an emerging player. Direct peers are BioCentury and DealForma.
Does MotionHall have an API?
No public API is recorded for MotionHall.
What industry is MotionHall in?
MotionHall's product category is Biopharma Deal Intelligence Software. Its primary akta.pro industry code is FSAEAIAK, Business-for-Sale Marketplaces & Listing Platforms. Its NAICS code is 425.